STERIS’ (TSE:STE – Free Report) – Analysts at Cormark cut their FY2024 EPS estimates for STERIS’ in a note issued to investors on Tuesday, November 5th. Cormark analyst B. Watson now anticipates that the company will earn $0.77 per share for the year, down from their prior estimate of $0.90.
STERIS’ (TSE:STE – Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported C$0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$0.12 by C$0.02. The business had revenue of C$231.38 million for the quarter, compared to analysts’ expectations of C$226.20 million.
STERIS’ Price Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Articles
- Five stocks we like better than STERIS’
- Airline Stocks – Top Airline Stocks to Buy Now
- What a Trump Win Looks Like for the Market Now and Into 2025
- How to Invest in the FAANG Stocks
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- What is Short Interest? How to Use It
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
